AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 80 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q1 2016. The put-call ratio across all filers is 6.56 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,382,735 | $22,455,000 | 6.33% |
| Wildcat Capital Management, LLC | 235,264 | $3,821,000 | 1.31% |
| Ghost Tree Capital, LLC | 150,000 | $2,436,000 | 0.79% |
| Redmile Group, LLC | 537,282 | $8,725,000 | 0.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,008,337 | $16,375,000 | 0.48% |
| Green Owl Capital Management, LLC | 35,000 | $568,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 154,006 | $2,501,000 | 0.30% |
| MARINER INVESTMENT GROUP LLC | 69,000 | $1,121,000 | 0.29% |
| DSC Advisors, L.P. | 26,129 | $424,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 197,800 | $3,212,000 | 0.12% |